Column 1 Column 2 Column 3 0 Metro Mining 1 Bx = US$/t CIF China 65,3 2 Discount for high silicia content -10% 3 Bx = US$/t CIF China effectiv 58,8 4 AUD /USD (long term plan) 0,85 5 CIF China in AUD/t 69,1 6 Shipping to china in AUD/t -15,0 7 FOB price in aud/t 54,1 8 Royalties in aud/t -5,4 9 effictive price sales price aud/t 48,7 10 operational costs aud/t -25,0 11 operational magin in aud/t 23,7 12 --------------------------------------------------------- -------------------------------- 13 Sales in MioT/Year 2,0 14 --------------------------------------------------------- -------------------------------- 15 Gross Profit in mio aud/year 47,5 16 interest in mio aud -2,4 (8% for 30 mio borrowing capital) 17 depreciation in mio aud -6,0 (60 Mio Capex at 10 year amortization period) 18 EBT in mio aud 39,1 19 Tax 20% -7,8 20 Profit /year in mio aud 31,2 21 multiplier 6 22 Total value company 187 23 24 Capex in Mio AUD 60 25 borrowing capital in Mio AUD 30 26 new own capital in Mio AUD 30 (300 mio new shares at 0,10 issue price beginning 2016) 27 28 Shares old 288 29 Shares new 300 30 Shares total 588 31 32 Value in mio Aud 187 33 Shares total in mio 588 34 Price Target in aud 0,32 35 actual price 0,036 36 potential 786%
- Forums
- ASX - By Stock
- MMI
- price target 32 cent
price target 32 cent
Featured News
Add MMI (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.7¢ |
Change
-0.001(2.08%) |
Mkt cap ! $279.9M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.6¢ | $530.7K | 11.29M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1045327 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 699384 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1045327 | 0.046 |
8 | 3461160 | 0.045 |
6 | 483198 | 0.044 |
3 | 109000 | 0.043 |
4 | 207500 | 0.042 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 699384 | 1 |
0.048 | 407372 | 3 |
0.049 | 2212306 | 4 |
0.050 | 3473900 | 9 |
0.051 | 530000 | 3 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
MMI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online